Chicago Trust’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-7,500
| Closed | -$207K | – | 346 |
|
|
2021
Q4 | $207K | Hold |
7,500
| – | – | 0.04% | 327 |
|
|
2021
Q3 | $242K | Sell |
7,500
-2,000
| -21% | -$64.5K | 0.05% | 291 |
|
|
2021
Q2 | $291K | Hold |
9,500
| – | – | 0.07% | 249 |
|
|
2021
Q1 | $289K | Buy |
+9,500
| New | +$289K | 0.1% | 168 |
|
|
2020
Q1 | – | Sell |
-9,500
| Closed | -$259K | – | 178 |
|
|
2019
Q4 | $259K | Hold |
9,500
| – | – | 0.11% | 155 |
|
|
2019
Q3 | $272K | Buy |
9,500
+2,000
| +27% | +$57.3K | 0.11% | 154 |
|
|
2019
Q2 | $208 | Hold |
7,500
| – | – | 0.09% | 178 |
|
|
2019
Q1 | $249 | Hold |
7,500
| – | – | 0.11% | 164 |
|
|
2018
Q4 | $218 | Buy |
7,500
+2,500
| +50% | +$73 | 0.1% | 150 |
|
|
2018
Q3 | $230K | Buy |
+5,000
| New | +$230K | 0.09% | 155 |
|
|
2016
Q1 | – | Sell |
-5,000
| Closed | -$216K | – | 160 |
|
|
2015
Q4 | $216K | Buy |
+5,000
| New | +$216K | 0.08% | 145 |
|